# Study of Personalized Cancer Therapy to Determine Response and Toxicity

> **NCT02478931** · — · RECRUITING · sponsor: **Shu Mei Kato** · enrollment: 10000 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02478931
- **Lead sponsor:** Shu Mei Kato
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2013-09-05
- **Primary completion:** 2026-09-05
- **Final completion:** 2027-09-05
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478931, "Study of Personalized Cancer Therapy to Determine Response and Toxicity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02478931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*